Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
F. Fanfulla, L. Demartini, P. Fulgoni, M. Buonocore, M. Barbieri, C. Bonezzi (Pavia, Italy). Daytime sleepiness in patients on intrathecal chronic opioid (IT) therapy is not related to sleep disordered breathing (SDB). Eur Respir J 2011; 38: Suppl. 55, 2250

Member's Comments

No comment yet.

Related content which might interest you: Adaptive servo-ventilation (ASV) therapy for sleep disordered breathing (SDB) associated with opioid medications Source: Annual Congress 2007 - Sleep apnoea and adaptive servo–ventilation Year: 2007 Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA). Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study Source: Eur Respir J 2009; 33: 1062-1067 Year: 2009 Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms Source: Eur Respir J 2011; 37: 98-105 Year: 2011 The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019 Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment Source: Eur Respir J 2013; 41: 593-600 Year: 2013 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Differences in age of sleep apnea patients with normalized and persistent excessive daytime sleepiness after nCPAP therapy Source: Annual Congress 2004 - CPAP therapy for OSA Year: 2004 Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome? Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 The impact of ageing and sex on the association between sleepiness and sleep disordered breathing Source: Eur Respir J 2012; 40: 386-393 Year: 2012 Daytime sleepiness and polysomnographic variables in sleep apnoea patients Source: Eur Respir J 2007; 30: 110-113 Year: 2007 Impact of bi-Level ventilation on sleep disordered breathing in patients using chronic opioids Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure Year: 2010 Nocturnal hypercapnia in eucapnic obese patients With sleep disordered breathing (SDB) Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013 Prevalence of residual sleepiness in patients with optimally treated sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 724s Year: 2005 Sleep architecture in patients with moderate to severe sleep apnea without daytime sleepiness Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation Year: 2007 Sexuality in patients with sleep related breathing disorders (SRBD) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Daytime sleepiness and cardiovascular complications in moderate to severe obstructive sleep apnoea (OSA) patients Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013 Effect of multiple-dose treatment with daridorexant on nighttime respiratory function in patients with mild and moderate obstructive sleep apnea (OSA) Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020